UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):October 10, 2019 (October 6, 2019)
TECHCARE CORP.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware | | 000-55680 | | 68-0080601 |
(State or Other Jurisdiction of Incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
| 1140 Avenue of the Americas, New York, NY | | 10036 |
| (Address of Principal Executive Offices) | | (Zip Code) |
(646) 380-6645
(Registrant’s telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
| Common Stock, par value $0.0001 per share | | TECR | | OTCQB |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
Item 8.01 Other Events.
On October 6, 2019, Mrs. Osnat Philipp, the Chief Executive Officer of Novomic Ltd. (“Novomic”), a wholly-owned subsidiary of TechCare Corp. (the “Company”), and the Company jointly agreed to terminate her employment agreement. Mrs. Philipp will continue to provide her services to Novomic as required under Israeli law until October 30, 2019, unless otherwise agreed to by Mrs. Philipp and the Company. Mrs. Philipp’s resignation was not as a result of any disagreement or dispute with either the Company or Novomic.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | TechCare Corp. |
| | | |
| | By: | /s/ Tali Dinar |
| | Name: | Tali Dinar |
| | Title: | Chief Financial Officer |
Date: October 10, 2019
